Tenon Medical, Inc. Sets Date for Second Quarter 2026 Earnings
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Tenon Medical (NASDAQ:TNON) will release its second quarter 2026 financial results for the period ended June 30, 2026 after market close on Thursday, August 13, 2026, followed by a conference call at 4:30 p.m. Eastern Time featuring a Q&A with covering analysts.
Investors can join via dial-in at 1-877-407-0792 (U.S.) or 1-201-689-8263 (international), or through a webcast titled “TNON Conference Call.” An audio replay will be available until August 27, 2026 on Tenon’s investor relations website or by telephone replay with access code 13761819.
According to Tenon Medical, the company develops medical devices for sacro-pelvic disorders and offers the Catamaran SI Joint Fusion System and, following an August 2025 asset acquisition from SiVantage and SIMPL Medical, the SImmetry+ SI Joint Fusion System.
Details
News Market Reaction – TNON
On Jul 30, the day this news came out, TNON closed 1.61% above the previous close.
Data tracked by StockTitan Argus for the Jul 30 session.
Key Figures
- Earnings release date
- August 13, 2026
- Second quarter 2026 results
- Reporting period end
- June 30, 2026
- Second quarter 2026
- Conference call time
- 4:30 p.m. Eastern Time
- August 13, 2026
- Replay availability
- August 27, 2026
- Audio playback available through this date
Previous Earnings date Reports
-
Scheduled first-quarter results and conference call for May 12
-
Scheduled fourth-quarter and full-year results with revenue ranges
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Key Terms
si joint medical
AI-generated analysis. How Rhea-AI works. Not financial advice.
LOS GATOS, CA / ACCESS Newswire / July 30, 2026 / Tenon Medical, Inc. (NASDAQ:TNON)("Tenon" or the "Company"), a medical device company dedicated to transforming care for patients with certain sacro-pelvic disorders, today announced plans to release financial results for the second quarter ended June 30, 2026 after market close on Thursday, August 13, 2026. The Company will also hold a conference call on the same day at 4:30 p.m. Eastern Time to discuss its financial results in further detail. The call will conclude with a Q&A session with its covering analysts.
Date: | Thursday, August 13, 2026 |
Time: | 4:30 p.m. Eastern time |
Dial-in: | 1-877-407-0792 |
International Dial-in: | 1-201-689-8263 |
Webcast: |
Please dial in at least 10 minutes before the start of the call to ensure timely participation.
An audio playback of the call will be available through August 27, 2026,on Tenon's Investor Relations website at http://ir.tenonmed.com/ or via telephone replay by dialing 1-844-512-2921 (USA) or 1-412-317-6671(International). The access code will be 13761819.
About Tenon Medical, Inc.
Tenon Medical, Inc. is a medical device company dedicated to transforming care for patients with certain sacro-pelvic disorders. Tenon was incorporated in the State of Delaware in 2012 and currently offers two systems to treat a diseased sacroiliac joint (the "SI Joint"). The Company has developed The Catamaran™ SI Joint Fusion System that offers a novel, less invasive approach to the SI Joint using a single, robust titanium implant. In August 2025, the Company acquired substantially allof the assets of SiVantage, Inc. and SIMPL Medical, LLC, including the SImmetry+® SI Joint Fusion System, which treats disorders of the SI Joint through a minimally invasive lateral access solution that incorporates well-established orthopedic fusion principles. Since the national launch of The Catamaran System in October 2022, Tenon is focused on three commercial opportunities: 1) primary SI Joint procedures, 2) revision procedures of failed SI Joint implants and 3) SI-Joint fusion adjunct to a spine fusion construct.
For more information, please visit www.tenonmed.com. Information on the Company's website does not constitute a part of and is not incorporated by reference into this press release.
The Tenon Medical logo shown above, and Catamaran®, PiSIF®, CAT PiSIF®, ETAD®, Posterior Inferior Sacroiliac Fusion®, CAT SIJ Fusion System®, Catamaran SIJ Fusion System®, Catamaran Inferior Posterior Fusion System®, Catamaran Transfixation Fusion System®, Catamaran Transfixation Fusion Device®, SImmetry® are registered trademarks of Tenon Medical, Inc. MAINSAILTM, and SImmetry+ are also trademarks of Tenon Medical, Inc.
IR Contact:
Shannon Devine
203-741-8811
MZ North America
tenon@mzgroup.us
SOURCE: Tenon Medical, Inc.
View the original press release on ACCESS Newswire
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.